· 2018
· 2017
· 2016
· 2015
· 2014
· 2013
· 2012
· 2011
· 2010
· 2009
· 2008
· 2007
· 2006
· 2005
· 2004
· 2003
· 2002
· 2001
· 2000년 이전




2013

1. Effect of conjugated linoleic acid, μ-calpain inhibitor, on pathogenesis of Alzheimer's disease. Lee E, Eom JE, Kim HL, Baek KH, Jun KY, Kim HJ, Lee M, Mook-Jung I, Kwon Y.Biochim Biophys Acta. 2013 Apr;1831(4):709-18. 

2. Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology. Moon M, Song H, Hong HJ, Nam DW, Cha MY, Oh MS, Yu J, Ryu H, Mook-Jung I.Cell Death Differ. 2013 Apr;20(4):630-8.  

3. A two-photon fluorescent probe for amyloid-β plaques in living mice. Heo CH, Kim KH, Kim HJ, Baik SH, Song H, Kim YS, Lee J, Mook-jung I, Kim HM. Chem Commun (Camb). 2013 Feb 14;49(13):1303-5.  

4. Amelioration of neurodegenerative diseases by cell death-induced cytoplasmic delivery of humanin. Park TY, Kim SH, Shin YC, Lee NH, Lee RK, Shim JH, Glimcher LH, Mook-Jung I, Cheong E,Kim WK, Honda F, Morio T, Lim JS, Lee SK.J Control Release. 2013 Mar 28;166(3):307-15.

5. Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis. Song H, Boo JH, Kim KH, Kim C, Kim YE, Ahn JH, Jeon GS, Ryu H, Kang DE, Mook-Jung I.Cell Death Differ. 2013 Apr;20(4):639-48.  

6. SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. Miyashita A, Koike A, Jun G, Wang LS, Takahashi S, Matsubara E, Kawarabayashi T, Shoji M,Tomita N, Arai H, Asada T, Harigaya Y, Ikeda M, Amari M, Hanyu H, Higuchi S, Ikeuchi T,Nishizawa M, Suga M, Kawase Y, Akatsu H, Kosaka K, Yamamoto T, Imagawa M, Hamaguchi T, Yamada M, Moriaha T, Takeda M, Takao T, Nakata K, Fujisawa Y, Sasaki K, Watanabe K,Nakashima K, Urakami K, Ooya T, Takahashi M, Yuzuriha T, Serikawa K, Yoshimoto S,Nakagawa R, Kim JW, Ki CS, Won HH, Na DL, Seo SW, Mook-Jung I; Alzheimer Disease Genetics Consortium, St George-Hyslop P, Mayeux R, Haines JL, Pericak-Vance MA, Yoshida M, Nishida N, Tokunaga K, Yamamoto K, Tsuji S, Kanazawa I, Ihara Y, Schellenberg GD,Farrer LA, Kuwano R. PLoS One. 2013;8(4):e58618. doi: 10.1371/journal.pone.0058618. Epub 2013 Apr 2.  

7. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology. Hong I, Kang T, Yoo Y, Park R, Lee J, Lee S, Kim J, Song B, Kim SY, Moon M, Yun KN, Kim JY, Mook-Jung I, Park YM, Choi S. J Alzheimers Dis. 2013 Jan 1;36(2):321-34. 

8. Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl) propyl thiourea template. Tran PT, Hoang VH, Thorat SA, Kim SE, Ann J, Chang YJ, Nam DW, Song H, Mook-Jung I,Lee J, Lee J. Bioorg Med Chem. 2013 Jul 1;21(13):3821-30.  

9. Synapsin-1 and tau reciprocal O-GlcNAcylation and phosphorylation sites in mouse brain synaptosomes. Kang MJ, Kim C, Jeong H, Cho BK, Ryou AL, Hwang D, Mook-Jung I, Yi EC. Exp Mol Med. 2013 Jun 28;45:e29. 

10. Mitochondrial dysfunction and calcium deregulation by the RanBP9-cofilin pathway. Roh SE, Woo JA, Lakshmana MK, Uhlar C, Ankala V, Boggess T, Liu T, Hong YH, Mook-Jung I, Kim SJ, Kang DE. FASEB J. 2013 Aug 27.

 

Laboratory for Alzheimer's Disease Research,
#215 Biomedical Research Building, Seoul National University College of Medicine
28 Yeongeon-dong, Jongno-gu, Seoul 110-799, Korea. Tel) +82-2-3668-7636, Fax) +82-2-3672-7352